Department of Public Policy, Rochester Institute of Technology, Rochester, New York, United States of America.
Department of Management and Public Policy, Rochester Institute of Technology, Rochester, New York, United States of America.
PLoS One. 2023 Mar 28;18(3):e0283442. doi: 10.1371/journal.pone.0283442. eCollection 2023.
The FDA's 510(k) process for medical devices is based on "substantial equivalence" to devices clearedpre-1976 or legally marketed thereafter, known as predicate devices. In the last decade, several high-profile device recalls have drawn attention to this regulatory clearance process and researchers have raised questions about the validity of the 510(k) process as a broad clearance mechanism. One of the issues raised is the risk of predicate creep, a cycle of technology change through repeated clearance of devices based on predicates with slightly different technological characteristics, such as materials and power sources, or have indications for different anatomical sites. This paper proposes a new way to identify potential "predicate creep" through the use of product codes and regulatory classifications. We test this method by applying it to a case study of a Robotic Assisted Surgery (RAS) device, the Intuitive Surgical Da Vinci Si Surgical System. We find that there is evidence of predicate creep using our method, and discuss implications of this method for research and policy.
美国食品和药物管理局(FDA)的 510(k) 医疗器械流程基于“实质等同”于 1976 年前批准或此后合法上市的设备,即所谓的前序设备。在过去的十年中,几次备受瞩目的设备召回事件引起了人们对这一监管批准流程的关注,研究人员对 510(k) 流程作为一种广泛的批准机制的有效性提出了质疑。其中一个问题是前序蔓延的风险,这是一种通过基于具有略微不同技术特征(如材料和电源)的前序设备的多次批准来实现技术变革的循环,或者具有不同解剖部位的适应症。本文提出了一种通过使用产品代码和监管分类来识别潜在“前序蔓延”的新方法。我们通过将该方法应用于机器人辅助手术(RAS)设备——直觉外科达芬奇 Si 手术系统的案例研究来测试该方法。我们发现,使用我们的方法有证据表明存在前序蔓延,并讨论了该方法对研究和政策的影响。